-
Recent Posts
- Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Spikes with Promise of Tasimelteon
- Is Enviro-Serv, Inc. (PINKSHEETS: EVSV) Any Closer to Generating Revenues?
- Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) Spikes on Earnings but is there More to the Numbers?
- Is Gold in the Future for FBC Holding, Inc. (OTCQB: FBCD)?
- Will it be Clear Sailing for Alas International Holdings, Inc. (PINKSHEETS: VDSC)?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: gene
Is Genetic Technologies Ltd. (NASDAQ: GENE) Positioned for Growth with Breast Cancer Risk Test?
Genetic Technologies Ltd. (NASDAQ: GENE) has put together a staggering day of growth on Wednesday as shares have jumped from a Tuesday close of 3.12 up to a high of 4.28 today with trading volume already topping the 2.2 million … Continue reading
Posted in Articles, NASDAQ
Tagged breast cancer, brevagen, cancer, gene, genetic technologies, investors, reproductive genetics
Leave a comment
Genetic Technologies Ltd. (NASDAQ: GENE) Positioning Itself for Launch of Breast Cancer Prognostic Test BREVAGen, Is There Substance Behind the Product?
There has been a lot of attention paid to Genetic Technologies Ltd. (NASDAQ: GENE) as of late and if what the company is saying is true then the hype is warranted. GENE announced last week that they expected to post … Continue reading
Posted in Articles, NASDAQ
Tagged breast cancer, brevagen, cancer, gene, genetic technologies, investors, molecular diagnostics, NASDAQ, penny stocks
Leave a comment
Healthcare Stocks Showing Strong Signs of Life: LXRX, NMTI, BASI, GENE, TEAR
Healthcare stocks climbed 0.23% as a sector on Thursday and a number of companies posted impressive double-digit percentage gains during the trading day. Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) took the honors for producing the biggest jump as shares spiked 48.53% … Continue reading
Posted in NASDAQ, News
Tagged basi, gene, healthcare stocks, investors, lexicon, lxrx, medical research, NASDAQ, nmt medical, nmti, occulogix, penny stocks, tear
Leave a comment
Healthcare Stocks Showing Life on Tuesday: GENE, BASI, ONXX, CRME, VVUS
Healthcare stocks showed plenty of life on Tuesday as the sector improved 0.17% on the day with Genetic Technologies Limited (ADR) (NASDAQ: GENE) showing the biggest percentage improvement with a 18.45% increase to close at 0.95. The company, which operates … Continue reading
Posted in NASDAQ, News
Tagged basi, crme, fda, gene, genetic technologies, healthcare stocks, investors, nasda, onxx, penny stocks, vivus, vvus
Leave a comment


